Small molecule inhibitors in acute myeloid leukemia: From the bench to the clinic

Keyphrases

• Acute Myeloid Leukemia 100%
• Small Molecule Inhibitors 100%
• Relapsed or Refractory 33%
• Therapeutic Intervention 33%
• Novel Therapeutics 33%
• Targeted Therapy 33%
• New Therapeutics 33%
• Gastrointestinal Stromal Tumor 33%
• Therapeutic Agents 33%
• Relapsed Disease 33%
• Chronic Myeloid Leukemia 33%
• Human Trials 33%
• Early Humans 33%
• Refractory Disease 33%
• Unmet Needs 33%
• Multiple Tumors 33%

Medicine and Dentistry

• Acute Myeloid Leukemia 100%
• Therapeutic Agent 66%
• Clinical Trial 33%
• Targeted Therapy 33%
• Gastrointestinal Stromal Tumor 33%
• Clinical Pathway 33%
• Proteus Syndrome 33%
• Chronic Myelogenous Leukemia 33%
• Diseases 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Acute Myeloid Leukemia 100%
• Clinical Trial 33%
• Multiple Cancer 33%
• Gastrointestinal Stromal Tumor 33%
• Chronic Myeloid Leukemia 33%
• Diseases 33%